Beer-Sheva, Israel

Gal Suez

USPTO Granted Patents = 3 

Average Co-Inventor Count = 3.6

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2019-2025

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Gal Suez: Innovator in Pharmaceutical Chemistry

Introduction

Gal Suez is a prominent inventor based in Beer-Sheva, Israel. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative processes and compounds. With a total of 3 patents to his name, Suez continues to push the boundaries of scientific research and development.

Latest Patents

Gal Suez's latest patents include a process for preparing 5-(fluoro-4-imino-3-methyl)-1-tosyl-3,4-dihydropyrimidine-(1H)-one and its derivatives. This invention provides a novel method for synthesizing a compound with a specific formula. Additionally, he has developed polymorphs of 5-fluoro-4-imino-3-methyl-1-tosyl-3,4-dihydropyrimidin-2-one, which offers a crystalline form of the compound, enhancing its potential applications in pharmaceuticals.

Career Highlights

Gal Suez is currently employed at Adama Makhteshim, Ltd., where he applies his expertise in developing innovative solutions for agricultural and pharmaceutical products. His work has been instrumental in advancing the company's research initiatives and product offerings.

Collaborations

Throughout his career, Gal Suez has collaborated with notable colleagues, including Michael Grabarnick and Samaa Alasibi. These partnerships have fostered a dynamic research environment, leading to groundbreaking discoveries and advancements in their respective fields.

Conclusion

Gal Suez stands out as a dedicated inventor in the pharmaceutical industry, with a focus on innovative processes and compounds. His contributions continue to impact the field positively, showcasing the importance of research and collaboration in driving scientific progress.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…